Article Details

Cara Therapeutics (CARA) Valuation Rose While Rho Capital Partners Has Decreased by $6.30 ...

Retrieved on: 2019-09-23 03:51:35

Tags for this article:

Click the tags to see associated articles and topics

Cara Therapeutics (CARA) Valuation Rose While Rho Capital Partners Has Decreased by $6.30 .... View article details on hiswai:

Excerpt

<div>Oakbrook Investments Llc decreased its stake in <b>Cme Group</b> (CME) by 4.71% based on its latest 2019Q2 regulatory filing with the SEC. Oakbrook ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up